BPMC - Blueprint Medicines EPS beats by $1.80 beats on revenue October, 29 2020 07:07 AM Blueprint Medicines Corporation Blueprint Medicines (BPMC): Q3 GAAP EPS of $11.16 beats by $1.80.Revenue of $745.12M (+8052.3% Y/Y) beats by $117.7M.Shares -0.37% PM.Press Release For further details see: Blueprint Medicines EPS beats by $1.80, beats on revenue